A Few Bright Spots In Bluebird bio Inc (NASDAQ: BLUE)

Bluebird bio Inc (NASDAQ:BLUE) currently has a daily average trading volume of 5.94M but it saw 3730177 shares traded in last market. With a market cap of 208.16M USD, the company’s current market price of $1.08 came falling about -6.90 while comparing to the previous closing price of $1.16. In past 52 weeks, the stock remained buoying in the range of price level as high as $5.53 and as low as $0.85.

Taking a look at 20-day trading activity of Bluebird bio Inc (BLUE) gives us an average price of $1.1439, while its current price level is -80.47% below from 52-week high level whereas it is 27.81% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.0248 while that of 200 days or SMA-200 reads an average of $1.6491. A closer look into the stock’s movement over the week reveals that its volatility is standing at 10.40% during that period while stretching the period over a month that decreases to 9.94%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 47.97 which implies that the stock is in neutral territory.

Morgan Stanley upgraded its recommendation for the stock as a “Equal-Weight” from “Underweight” on December 08, 2023 while assigning a price target range of $3-$7.

Over the week, BLUE’s stock price is moving -10.00% down while it is 17.00% when we observe its performance for the past one month. Year-to-date it is -21.74% down and over the past year, the stock is showing a downside performance of -71.05%.

Currently, Bluebird bio Inc’s total number of outstanding shares is 192.74M with 0.36% of that held by the insiders while 58.95% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -20.06% and return on equity (ROE) at -47.81%. Stock’s beta reads 0.82. Stock has a price to book (P/B) ratio of 0.52 while price to sale or P/S ratio amounts to 9.58. Its return on asset (ROA) is -16.08% on average.